|
Usanova A.A., Lavrenova E.A., Kunyaeva T.A., Kuzma F., Novikova E.K., Sergutova N.P., Chatkina T.A.
Modern aspects of use of tirzepatide – the first dual agonist of glucagon-like peptide-1 and glucosependent insulinotropic peptide receptors
|
№8 / 2023
|
|
Iskenderov B.G., Lokhina T.V., Mozhzhukhina I.N., Berenshtein N.V., Zaitseva A.V.
Influence of vascular remodelling and reduced heart rate variability at indapamide efficacy in patients with arterial hypertension
|
№8 / 2023
|
|
Safronenko V.A., Chesnikova A.I.
Treatment of comorbid patients over 80 years old: Focus at arterial hypertension (analysis of real clinical practice)
|
№8 / 2023
|
|
Prekina V.I., Kunyaeva T.A., Shokina S.V., Samolvina O.G., Skopina Yu.A.
Correction of risk factors in patients with atrial fibrillation
|
№8 / 2023
|
|
Kobzeva N.D., Gelpey M.A., Zibrova L.A., Skoropis A.V., Shchetinkina D.A.
Clinical case of a comorbid patient with ischemic brain stroke
|
№5 / 2023
|
|
Syrov A.V.
Indapamide in the treatment of arterial hypertension
|
№4 / 2023
|
|
|
№3 (приложение) / 2023
|
|
|
№3 (приложение) / 2023
|
|
|
№3 (приложение) / 2023
|
|
|
№3 (приложение) / 2023
|
|
|
№3 (приложение) / 2023
|
|
|
№3 (приложение) / 2023
|
Русский
